REGENXBIO Inc. (RGNX) Operating margin 2016–2025
REGENXBIO Inc. (RGNX) operating margin by fiscal year — reported operating income divided by reported revenue.
-94.6%FY2025 · since FY2016: -1423.8% → -94.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -94.6% | +185.5 pp |
| FY2024 | -280.0% | +17.1 pp |
| FY2023 | -297.1% | -63.9 pp |
| FY2022 | -233.2% | -267.2 pp |
| FY2021 | 34.0% | +111.2 pp |
| FY2020 | -77.1% | +345.8 pp |
| FY2019 | -422.9% | -463.2 pp |
| FY2018 | 40.3% | +770.5 pp |
| FY2017 | -730.2% | +693.7 pp |
| FY2016 | -1423.8% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNX financial trends
RGNX RevenueRGNX Net incomeRGNX Net marginRGNX Gross profitRGNX Gross marginRGNX Operating incomeRGNX Operating cash flowRGNX Free cash flowRGNX Capital expendituresRGNX Return on equityRGNX Stock buybacksRGNX Dividends paidRGNX Total assetsRGNX Total liabilitiesRGNX Shareholders’ equityRGNX overview →